AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
View Top Employees from AlloVir, an ElevateBio CompanyWebsite | http://www.allovir.com |
Revenue | $11.4 million |
Funding | $9 million |
Employees | 142 (142 on RocketReach) |
Address | 1100 Winter Street, Waltham, Massachusetts 02451, US |
Phone | (936) 662-3626 |
Industry | Biotechnology Research, Biotechnology, Pharmaceuticals, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular AlloVir, an ElevateBio Company employee's phone or email?
The AlloVir, an ElevateBio Company annual revenue was $11.4 million in 2024.
Diana Brainard is the CEO of AlloVir, an ElevateBio Company.
142 people are employed at AlloVir, an ElevateBio Company.
AlloVir, an ElevateBio Company is based in Waltham, Massachusetts.
The NAICS codes for AlloVir, an ElevateBio Company are [3254, 325, 32].
The SIC codes for AlloVir, an ElevateBio Company are [28, 283].